ArticleAlimentary pharmacology & therapeutics2024

A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States.

Nikita Mittal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.